Veronica Galvan
#110,686
Most Influential Person Now
Researcher
Veronica Galvan's AcademicInfluence.com Rankings
Veronica Galvanpsychology Degrees
Psychology
#4229
World Rank
#4722
Historical Rank
Cognitive Science
#251
World Rank
#252
Historical Rank
Social Psychology
#444
World Rank
#461
Historical Rank
Cognitive Psychology
#627
World Rank
#659
Historical Rank
Download Badge
Psychology
Veronica Galvan's Degrees
- PhD Psychology University of California, Berkeley
- Masters Cognitive Science Stanford University
- Bachelors Psychology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Veronica Galvan Influential?
(Suggest an Edit or Addition)According to Wikipedia, Veronica Galvan is a Professor and the Donald W. Reynolds Endowed Chair of Aging Research in the Department of Biochemistry and Molecular Biology at the University of Oklahoma Health Sciences Center. Since December 2022, she has served as Director of the Oklahoma Nathan Shock Center on Aging. She also serves as co-director of the Center for Geroscience and Healthy Brain Aging at the University of Oklahoma Health Sciences Center.
Veronica Galvan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease (2010) (865)
- Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice. (2004) (459)
- Mechanisms of Vascular Aging. (2018) (329)
- Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner. (1998) (272)
- Correction for Galvan et al., Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664 (2006) (224)
- Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice (2012) (198)
- In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP. (2010) (184)
- Transplantation of Human Neural Precursor Cells in Matrigel Scaffolding Improves Outcome from Focal Cerebral Ischemia after Delayed Postischemic Treatment in Rats (2010) (182)
- Glycoprotein D or J Delivered in transBlocks Apoptosis in SK-N-SH Cells Induced by a Herpes Simplex Virus 1 Mutant Lacking Intact Genes Expressing Both Glycoproteins (2000) (159)
- Chronic Rapamycin Restores Brain Vascular Integrity and Function Through NO Synthase Activation and Improves Memory in Symptomatic Mice Modeling Alzheimer’s Disease (2013) (157)
- Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease (2013) (140)
- Aβ induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597–624) (2006) (130)
- Deficits in Synaptic Transmission and Learning in Amyloid Precursor Protein (APP) Transgenic Mice Require C-Terminal Cleavage of APP (2006) (128)
- Neurogenesis in the aging brain (2007) (122)
- Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain (2011) (110)
- Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease (2015) (104)
- How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story (2015) (102)
- Rapamycin and Alzheimer’s disease: Time for a clinical trial? (2019) (101)
- Herpes Simplex Virus 1 Blocks Caspase-3-Independent and Caspase-Dependent Pathways to Cell Death (1999) (100)
- Caspase cleavage of members of the amyloid precursor family of proteins (2002) (99)
- Netrin-1 interacts with amyloid precursor protein and regulates amyloid-β production (2009) (97)
- Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease (2014) (92)
- Polyphosphate: A Conserved Modifier of Amyloidogenic Processes. (2016) (91)
- Type 1 Insulin-like Growth Factor Receptor (IGF-IR) Signaling Inhibits Apoptosis Signal-regulating Kinase 1 (ASK1)* (2003) (89)
- Differential activation of mTOR complex 1 signaling in human brain with mild to severe Alzheimer's disease. (2013) (83)
- Over‐expression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by rapamycin and is sufficient to ameliorate Alzheimer's‐like deficits in mice modeling the disease (2013) (79)
- Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice (2015) (75)
- Vascular endothelial growth factor improves recovery of sensorimotor and cognitive deficits after focal cerebral ischemia in the rat (2006) (73)
- Inborn Errors of RNA Lariat Metabolism in Humans with Brainstem Viral Infection (2018) (72)
- Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment. (2018) (71)
- Signal transduction in Alzheimer disease: p21‐activated kinase signaling requires C‐terminal cleavage of APP at Asp664 (2008) (70)
- Bcl-2 Blocks a Caspase-Dependent Pathway of Apoptosis Activated by Herpes Simplex Virus 1 Infection in HEp-2 Cells (2000) (67)
- Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer’s disease (2017) (66)
- Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer’s Disease and Related Tauopathies (2017) (65)
- Demonstration of impaired neurovascular coupling responses in TG2576 mouse model of Alzheimer’s disease using functional laser speckle contrast imaging (2017) (65)
- A pilot proteomic study of amyloid precursor interactors in Alzheimer's disease (2005) (65)
- Obesity in Aging Exacerbates Neuroinflammation, Dysregulating Synaptic Function-Related Genes and Altering Eicosanoid Synthesis in the Mouse Hippocampus: Potential Role in Impaired Synaptic Plasticity and Cognitive Decline (2018) (62)
- Divergent tissue and sex effects of rapamycin on the proteasome-chaperone network of old mice (2014) (62)
- Glial alterations from early to late stages in a model of Alzheimer's disease: Evidence of autophagy involvement in Aβ internalization (2016) (59)
- Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor proteinΞ (2011) (55)
- Neurogenesis in the adult brain: implications for Alzheimer's disease. (2007) (54)
- Endogenous Neural Stem Cells in the Adult Brain (2007) (52)
- Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664 (2008) (48)
- Monkeypox: considerations for the understanding and containment of the current outbreak in non-endemic countries (2022) (46)
- C-terminal cleavage of the amyloid-beta protein precursor at Asp664: a switch associated with Alzheimer's disease. (2008) (46)
- Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load (2021) (44)
- Hydrogen sulfide ameliorates aging-associated changes in the kidney (2018) (43)
- mTOR drives cerebrovascular, synaptic, and cognitive dysfunction in normative aging (2019) (40)
- Interaction of checkpoint kinase 1 and the X‐linked inhibitor of apoptosis during mitosis (2004) (38)
- Tau phosphorylation in Alzheimer’s disease (2007) (36)
- Decreased in vitro Mitochondrial Function is Associated with Enhanced Brain Metabolism, Blood Flow, and Memory in Surfl-Deficient Mice (2013) (36)
- Effect of neural precursor proliferation level on neurogenesis in rat brain during aging and after focal ischemia (2009) (35)
- Importance of the caspase cleavage site in amyloid-β protein precursor. (2010) (30)
- Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease. (2016) (29)
- A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review (2018) (26)
- In Vivo Generation of Lung and Thyroid Tissues from Embryonic Stem Cells using Blastocyst Complementation. (2020) (26)
- Increases in hypertension-induced cerebral microhemorrhages exacerbate gait dysfunction in a mouse model of Alzheimer’s disease (2020) (25)
- Do proteomics analyses provide insights into reduced oxidative stress in the brain of an Alzheimer disease transgenic mouse model with an M631L amyloid precursor protein substitution and thereby the importance of amyloid-beta-resident methionine 35 in Alzheimer disease pathogenesis? (2012) (25)
- Reversal of learning deficits in hAPP transgenic mice carrying a mutation at Asp664: A role for early experience (2010) (21)
- Interaction of ASK1 and the β-amyloid precursor protein in a stress-signaling complex (2007) (21)
- mTOR drives cerebral blood flow and memory deficits in LDLR−/− mice modeling atherosclerosis and vascular cognitive impairment (2018) (20)
- Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer’s disease-like neuroinflammation and cognitive impairment (2021) (20)
- The role of vascular endothelial growth factor in neurogenesis in adult brain. (2006) (17)
- Netrin-1 Interrupts Amyloid-β Amplification, Increases sAβPPα in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer's Disease. (2016) (16)
- mTOR Attenuation with Rapamycin Reverses Neurovascular Uncoupling and Memory Deficits in Mice Modeling Alzheimer's Disease (2021) (12)
- Development of a high-throughput screen targeting caspase-8-mediated cleavage of the amyloid precursor protein. (2012) (7)
- Caspase cleavage of the amyloid precursor protein is prevented after overexpression of bcl-2 in a triple transgenic mouse model of Alzheimer's disease. (2009) (6)
- Endogenously EGFP-Labeled Mouse Embryonic Stem Cells. (2011) (4)
- Genetic and pharmacologic proteasome augmentation ameliorates Alzheimer’s-like pathology in mouse and fly APP overexpression models (2022) (4)
- mTOR in cerebrovascular disease (2019) (3)
- Editorial: Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans (2021) (3)
- An evaluation of the SARS-CoV-2 epidemic 16 days after the end of social confinement in Hungary (2020) (2)
- DIFFERENTIAL EXPRESSION AND REDOX PROTEOMICS ANALYSES OF AN ALZHEIMER DISEASE TRANSGENIC MOUSE MODEL : EFFECTS OF THE AMYLOID-PEPTIDE OF AMYLOID PRECURSOR (2011) (2)
- Brain cellular senescence in mouse models of Alzheimer’s disease (2021) (2)
- Henipaviruses: an expanding global public health concern? (2022) (2)
- Brain cellular senescence in mouse models of Alzheimer’s disease (2022) (2)
- TAU-INDUCED ASTROCYTE SENESCENCE: A NOVEL MECHANISM FOR NEURONAL DYSFUNCTION IN ALZHEIMER’S DISEASE (2019) (2)
- Differential Expression and Redox Proteomics Analyses of an Alzheimer Disease Transgenic Mouse Model: Effects of the Amyloid-β Peptide of APPΞ (2011) (1)
- MTOR PROMOTES BBB BREAKDOWN IN A MODEL OF ALZHEIMER’S DISEASE (2019) (1)
- Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease (2011) (1)
- NITRIC OXIDE SYNTHASE DYSFUNCTION UNDERLIES CEREBROVASCULAR DEFICITS IN A MOUSE MODEL OF TAUOPATHY (2019) (1)
- Correction to: Primary neuron and astrocyte cultures from postnatal Callithrix jacchus: a non-human primate in vitro model for research in neuroscience, nervous system aging, and neurological diseases of aging (2020) (1)
- Corrigendum to “Chronic inhibition of mTOR by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice” [Neuroscience 223 (2012) 102–113] (2015) (1)
- San Antonio Nathan Shock Center: your one-stop shop for aging research (2021) (1)
- Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease (2011) (1)
- Correction to: Hydrogen sulfide ameliorates aging-associated changes in the kidney (2021) (1)
- TOR-dependent cerebrovascular aging in Alzheimer's disease. (2014) (0)
- mTOR regulates chaperone networks and cognitive outcomes in mice modeling Alzheimer's disease (2011) (0)
- Gabriella Glycoproteins Lacking Intact Genes Expressing Both by a Herpes Simplex Virus 1 Mutant Blocks Apoptosis in SKN-SH Cells Induced trans Glycoprotein D or J Delivered in (2000) (0)
- NITRIC OXIDE SYNTHASE DYSFUNCTION UNDERLIES CEREBROVASCULAR DEFICITS IN MOUSE MODELS OF TAUOPATHY (2019) (0)
- Swimming training-to-criterion and pre-exposure to MWM are required for complete restoration of learning in APP transgenic mice carrying a mutation in Asp664 (2009) (0)
- Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer’s disease (2017) (0)
- Roizman Caspase-Dependent Pathways to Cell Death Caspase-3-Independent and Herpes Simplex Virus 1 Blocks (1999) (0)
- The Use of Mouse-Mouse and Mouse-Rat Chimeras to Generate Lung Tissue from Embryonic Stem Cells (2020) (0)
- Primary neuron and astrocyte cultures from postnatal Callithrix jacchus: a non-human primate in vitro model for research in neuroscience, nervous system aging, and neurological diseases of aging (2020) (0)
- MTOR-DRIVEN ALTERATIONS IN THE BRAIN MICROVASCULAR PROTEOME IN ALZHEIMER’S DISEASE (2019) (0)
- Porphyrin and Phthalocyanine Antiscrapie Compounds (2000) (0)
- Demonstration of impaired neurovascular coupling responses in TG2576 mouse model of Alzheimer’s disease using functional laser speckle contrast imaging (2017) (0)
- NEUROVASCULAR COUPLING DEFICITS ARISE PRIOR TO COGNITIVE DYSFUNCTION IN A MOUSE MODEL OF ALZHEIMER’S DISEASE (2018) (0)
- O4-05-03 A key role of the C-terminal cleavage of APP in Alzheimer’s disease (2006) (0)
- TOR drives neuronal and brain vascular dysfunction in mouse models of Alzheimer’s disease (2017) (0)
- AGE-RELATED PRESERVATION OF MOTOR NERVE CONDUCTION VELOCITY IN NEURONAL MTORC1 KNOCKDOWN MICE (2019) (0)
- MECHANISMS OF NEUROPROTECTION BY MTOR INHIBITORS (2019) (0)
- Comparative preclinical evaluation of a microtubule PET tracer with a beta‐amyloid PET tracer in AD mice (2021) (0)
- Here, there and everywhere: Disconnecting healthspan from lifespan by knocking down mTORC1 in neurons (2017) (0)
- Role of neuronal mTOR in aging (2011) (0)
- TOR AS A KEY REGULATOR OF NEURONAL AND BRAIN VASCULAR FUNCTION IN MOUSE MODELS OF ALZHEIMER’S DISEASE (2016) (0)
- Age-related impairment of metabovascular coupling during cortical spreading depolarizations. (2017) (0)
- Loss of blood‐brain barrier properties in association with endoplasmic reticulum stress in vascular cells from in vivo and in vitro models of Alzheimer’s disease (2021) (0)
- Erratum: Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664 (Proceedings of the National Academy of Sciences of the United States of America (2006) 103, (7130-7135)) (2007) (0)
- Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer’s disease-like neuroinflammation and cognitive impairment (2021) (0)
- TOR AND NO AS REGULATORS OF BRAIN VASCULAR FUNCTION IN A MOUSE MODEL OF AD (2014) (0)
- PROPAGATION OF SOLUBLE TAU AGGREGATES IN BRAIN MICROVASCULAR ENDOTHELIAL CELLS PROMOTES CELLULAR SENESCENCE/SASP AND BLOCKS ENOS ACTIVATION (2019) (0)
- Cerebrovascular dysfunction links aging to neurological disease (2020) (0)
- Soluble pathogenic tau enters brain vascular endothelial cells and drives cellular senescence and brain microvascular dysfunction in a mouse model of tauopathy (2023) (0)
- Hydrogen sulfide ameliorates aging-associated changes in the kidney (2018) (0)
- Correction to: Primary neuron and astrocyte cultures from postnatal Callithrix jacchus: a non-human primate in vitro model for research in neuroscience, nervous system aging, and neurological diseases of aging (2022) (0)
- Rapamycin restores peripheral blood flow in aged mice and in mouse models of atherosclerosis and Alzheimer's disease. (2023) (0)
- Correction to: Hydrogen sulfide ameliorates aging-associated changes in the kidney (2021) (0)
- Editorial: Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans (2021) (0)
- Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load (2021) (0)
- Effect of Nrf2 Loss on Senescence and Cognition of Tau-Based P301S Mice (2022) (0)
- A COMPARATIVE ANALYSIS OF THE METABOLOMIC INFLUENCES ON LONGEVITY TOR IN NEUROVASCULAR PATHWAYS OF ALZHEIMER’S AND RELATED AGE-ASSOCIATED NEUROLOGICAL DISEASE (2015) (0)
This paper list is powered by the following services:
Other Resources About Veronica Galvan
What Schools Are Affiliated With Veronica Galvan?
Veronica Galvan is affiliated with the following schools:
